Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection

Aim: to analyze the effectiveness of intravenous ozone therapy in long COVID-19 patients experienced community-acquired polysegmental pneumonia (associated with SARS-CoV2 infection). Materials and methods. The study involved 42 long COVID-19 individuals aged 41–82 years who underwent rehabilitati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I. B. Baranova, A. F. Gumeniuk, A. I. Semenenko, I. A. Iliuk, I. P. Osypenko
Formato: article
Lenguaje:EN
RU
UK
Publicado: Zaporozhye State Medical University 2021
Materias:
R
Acceso en línea:https://doi.org/10.14739/2310-1210.2021.6.233891
https://doaj.org/article/17137e2bcd9242af96e785f7628b162e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:17137e2bcd9242af96e785f7628b162e
record_format dspace
spelling oai:doaj.org-article:17137e2bcd9242af96e785f7628b162e2021-11-04T09:24:27ZOzone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infectionhttps://doi.org/10.14739/2310-1210.2021.6.2338912306-41452310-1210https://doaj.org/article/17137e2bcd9242af96e785f7628b162e2021-11-01T00:00:00Zhttp://zmj.zsmu.edu.ua/article/view/233891/241651https://doaj.org/toc/2306-4145https://doaj.org/toc/2310-1210Aim: to analyze the effectiveness of intravenous ozone therapy in long COVID-19 patients experienced community-acquired polysegmental pneumonia (associated with SARS-CoV2 infection). Materials and methods. The study involved 42 long COVID-19 individuals aged 41–82 years who underwent rehabilitation after community-acquired polysegmental pneumonia associated with SARS-CoV2 infection. The patients were examined and followed up subjectively (by the G. Borg and PCFS scales) and objectively (oxygen saturation, C-reactive protein, ferritin, D-dimer, urea and creatinine, 6-minute walk test). All patients received similar medicamentous therapy, and combined intravenous ozone therapy was additionally prescribed to the main group patients (n = 21): an alternate-day infusion of 200 ml ozonized saline at a concentration of 20 mg/ml and major autohemotherapy (100 ml ozonized saline at a concentration of 30 mg/ml mixed with 100 ml of the patient’s blood), 10 sessions per treatment course. Results. The integrated approach to the complex program of long COVID-19 treatment and rehabilitation for patients after pneumonia associated with SARS-CoV2 infection using intravenous ozone therapy has demonstrated its significant effectiveness based on the objective and subjective findings (P < 0.01). Twice as many patients in the main group (n = 18) achieved endpoints of the study (absence of dyspnea, normalization of blood biochemical markers and oxygen saturation levels, restoration of exercise tolerance) as compared to the control group (n = 9). Conclusions. The use of combined intravenous ozone therapy (alternating infusion of ozonized saline and ozonized saline mixed with the patient’s blood) in the rehabilitation program for patients after experienced community-acquired polysegmental pneumonia associated with SARS-CoV2 infection is pathogenetically substantiated, effective and cost-effective addition to complex health recovery tools. I. B. BaranovaA. F. GumeniukA. I. SemenenkoI. A. IliukI. P. OsypenkoZaporozhye State Medical Universityarticlerehabilitationozonotherapypneumonia viralsars-cov2 infectionlong-term covid-19MedicineRENRUUKZaporožskij Medicinskij Žurnal, Vol 23, Iss 6, Pp 752-758 (2021)
institution DOAJ
collection DOAJ
language EN
RU
UK
topic rehabilitation
ozonotherapy
pneumonia viral
sars-cov2 infection
long-term covid-19
Medicine
R
spellingShingle rehabilitation
ozonotherapy
pneumonia viral
sars-cov2 infection
long-term covid-19
Medicine
R
I. B. Baranova
A. F. Gumeniuk
A. I. Semenenko
I. A. Iliuk
I. P. Osypenko
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
description Aim: to analyze the effectiveness of intravenous ozone therapy in long COVID-19 patients experienced community-acquired polysegmental pneumonia (associated with SARS-CoV2 infection). Materials and methods. The study involved 42 long COVID-19 individuals aged 41–82 years who underwent rehabilitation after community-acquired polysegmental pneumonia associated with SARS-CoV2 infection. The patients were examined and followed up subjectively (by the G. Borg and PCFS scales) and objectively (oxygen saturation, C-reactive protein, ferritin, D-dimer, urea and creatinine, 6-minute walk test). All patients received similar medicamentous therapy, and combined intravenous ozone therapy was additionally prescribed to the main group patients (n = 21): an alternate-day infusion of 200 ml ozonized saline at a concentration of 20 mg/ml and major autohemotherapy (100 ml ozonized saline at a concentration of 30 mg/ml mixed with 100 ml of the patient’s blood), 10 sessions per treatment course. Results. The integrated approach to the complex program of long COVID-19 treatment and rehabilitation for patients after pneumonia associated with SARS-CoV2 infection using intravenous ozone therapy has demonstrated its significant effectiveness based on the objective and subjective findings (P < 0.01). Twice as many patients in the main group (n = 18) achieved endpoints of the study (absence of dyspnea, normalization of blood biochemical markers and oxygen saturation levels, restoration of exercise tolerance) as compared to the control group (n = 9). Conclusions. The use of combined intravenous ozone therapy (alternating infusion of ozonized saline and ozonized saline mixed with the patient’s blood) in the rehabilitation program for patients after experienced community-acquired polysegmental pneumonia associated with SARS-CoV2 infection is pathogenetically substantiated, effective and cost-effective addition to complex health recovery tools.
format article
author I. B. Baranova
A. F. Gumeniuk
A. I. Semenenko
I. A. Iliuk
I. P. Osypenko
author_facet I. B. Baranova
A. F. Gumeniuk
A. I. Semenenko
I. A. Iliuk
I. P. Osypenko
author_sort I. B. Baranova
title Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
title_short Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
title_full Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
title_fullStr Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
title_full_unstemmed Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
title_sort ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with sars-cov2 infection
publisher Zaporozhye State Medical University
publishDate 2021
url https://doi.org/10.14739/2310-1210.2021.6.233891
https://doaj.org/article/17137e2bcd9242af96e785f7628b162e
work_keys_str_mv AT ibbaranova ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection
AT afgumeniuk ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection
AT aisemenenko ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection
AT iailiuk ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection
AT iposypenko ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection
_version_ 1718444945158701056